Marker paths. MAP Workshop (Multi-cohort Analysis Project).
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology; D000328:Adult; D000704:Analysis of Variance; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D015331:Cohort Studies; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology; D015528:HIV Seroprevalence / Q000639:trends*; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood*; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D011159:Population Surveillance; D015215:Zidovudine / Q000627:therapeutic use; D001613:beta 2-Microglobulin / Q000032:analysis*
D007070:Immunoglobulin A; D001613:beta 2-Microglobulin; D015215:Zidovudine